IVATELGG Trademark

Trademark Overview


On Monday, July 8, 2024, a trademark application was filed for IVATELGG with the United States Patent and Trademark Office. The USPTO has given the IVATELGG trademark a serial number of 79402374. The federal status of this trademark filing is REGISTERED as of Tuesday, April 22, 2025. This trademark is owned by Boehringer Ingelheim International GmbH. The IVATELGG trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the blood and blood forming organs; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; pharmaceutical preparations for the treatment and prevention ...
ivatelgg

General Information


Serial Number79402374
Word MarkIVATELGG
Filing DateMonday, July 8, 2024
Status700 - REGISTERED
Status DateTuesday, April 22, 2025
Registration Number7764649
Registration DateTuesday, April 22, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 4, 2025

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the blood and blood forming organs; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; pharmaceutical preparations for the treatment and prevention of infectious diseases and disorders and viral infections; pharmaceutical preparations for the prevention and treatment of oncological and auto-immune diseases and disorders; pharmaceutical preparations, namely, cell based immune therapeutics for treatment of cancer, for treatment of immunological diseases, and treatment of infectious diseases.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 29, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBoehringer Ingelheim International GmbH
Party Type30 - Original Registrant
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Party NameBoehringer Ingelheim International GmbH
Party Type20 - Owner at Publication
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Party NameBoehringer Ingelheim International GmbH
Party Type10 - Original Applicant
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Trademark Events


Event DateEvent Description
Thursday, August 15, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Thursday, August 29, 2024LIMITATION FROM ORIGINAL APPLICATION ENTERED
Tuesday, October 1, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 1, 2024APPLICATION FILING RECEIPT MAILED
Saturday, December 28, 2024ASSIGNED TO EXAMINER
Monday, December 30, 2024NON-FINAL ACTION WRITTEN
Tuesday, December 31, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, February 3, 2025REFUSAL PROCESSED BY MPU
Tuesday, February 4, 2025NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, February 7, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 7, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 7, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 10, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, February 22, 2025REFUSAL PROCESSED BY IB
Wednesday, February 26, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 4, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 4, 2025PUBLISHED FOR OPPOSITION
Tuesday, April 22, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, April 22, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, July 23, 2025FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, November 12, 2025FINAL DISPOSITION PROCESSED
Wednesday, November 12, 2025FINAL DISPOSITION NOTICE SENT TO IB
Sunday, November 30, 2025FINAL DECISION TRANSACTION PROCESSED BY IB